Greece vs Maldives: The number of people with susceptibility test result for rifampicin
Greece
55
in 2021
Maldives
46
in 2021
Greece rank
121st
Maldives rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Greece
- Maldives
How they compare
Greece currently reports 55 against 46 in Maldives, a difference of 9.
That makes Greece's figure about 1.2 times Maldives's.
Across all 5 years both countries report, Greece has been ahead every year.
Greece ranks 121st and Maldives ranks 123rd of 155 countries.
Greece has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 149.33 | 76 | 73.33 | Greece |
| 2020s | 159 | 44.5 | 114.5 | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Greece or Maldives?
- Greece, at 55 against 46 in Maldives as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Greece and Maldives?
- 9, with Greece ahead.
- How many years of comparable data are there for Greece and Maldives?
- 5 years are reported by both, from 2017 to 2021.
- How do Greece and Maldives rank globally for the number of people with susceptibility test result for rifampicin?
- Greece ranks 121st and Maldives ranks 123rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.